CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products. The company's primary product and candidates in hematology/oncology include: EVOMELA (Melphalan for Injection), an intravenous formulation of melphalan commercialized in the multiple myeloma treatment setting in the United States; CNCT19, which targets CD19, a B-cell surface protein expressed during all phases of B-cell development and a validated target for B-cell driven hematological malignancies; CID-103, an investigational anti-CD38 monoclonal antibody being developed for the treatment of patients with multiple myeloma.

Coty and its subsidiaries are a beauty company. The company manufactures, markets, sells and distributes beauty products, including fragrances, color cosmetics, hair care products and skin and body related products. The company is organized into three divisions, which is also its operating and reportable segments: Consumer Beauty, Luxury and Professional Beauty. Consumer Beauty is primarily focused on color cosmetics, retail hair coloring and styling products, body care and mass fragrances. Luxury is primarily focused on fragrances, skincare and cosmetics. Professional Beauty is primarily focused on hair and nail care products for salon personnel.

Employers Holdings is a holding company. Through its wholly owned insurance subsidiaries, the company is engaged as a providers of workers' compensation insurance and services focused on select, small businesses engaged in low-to-medium hazard industries. The company provides insurance through Employers Insurance Company of Nevada, Employers Compensation Insurance Company, Employers Preferred Insurance Company, Employers Assurance Company and Cerity Insurance Company. Workers' compensation provides insurance coverage for the statutorily prescribed benefits that employers are required to provide to their employees who may be injured or suffer illness in the course of employment.

Flushing Financial is a bank holding company. The company's primary business operation is through its subsidiary, Flushing Bank. The company's primary business is accepting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, mainly in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans and, to a lesser extent, one-to-four family; construction loans; small business administration loans; mortgage loan surrogates such as mortgage-backed securities; and U.S. government securities, corporate fixed-income securities and other marketable securities.

FTS International is a provider of hydraulic fracturing services. The company's services improve hydrocarbon flow from oil and natural gas wells drilled by exploration and production (E&P) companies in shale and other resource formations. The company manufactures various components used by its fleets, including fabrication of pumps and consumables used in pumps. The company performs substantially all the maintenance, repair and refurbishment of its fleets, including the rebuilding of engines and transmissions. The company's primary service is providing hydraulic fracturing services to E&P companies. These services improve hydrocarbon flow in oil and natural gas wells, thus increasing the amount of hydrocarbons recovered.

Golub Capital BDC is registered as an externally managed, closed-end, non-diversified management investment company. The company makes investments primarily in one stop (a loan that combines characteristics of first lien senior secured loans and second lien or subordinated loans) and other senior secured loans of middle-market companies that are, in most cases, sponsored by private equity firms. The company's investment objective is to generate existing income and capital appreciation by investing primarily in one stop and other senior secured loans of United States middle-market companies.

Kodiak Sciences is a clinical stage biopharmaceutical company focusing on therapeutics to treat chronic, high-prevalence retinal diseases. The company's main product candidate is KSI-301, a biologic therapy built with the company's antibody biopolymer conjugate platform, which is designed to maintain drug levels in ocular tissues. KSI-301 is used to treat patients with wet age-related macular degeneration, diabetic retinopathy, including diabetic macular edema, and macular edema due to retinal vein occlusion. The company has applied its antibody biopolymer conjugate platform to develop additional product candidates beyond KSI-301, including KSI-501, its bispecific anti-IL-6/VEGF bioconjugate.

Lazydays operates recreation vehicle (RV) dealerships and provides a portfolio of products and services for RV owners and outdoor enthusiasts. The company arranges for financing for vehicle purchases through third-party financing sources in exchange for a commission payable to it. The company provides third-party protection plans and services to the purchasers of its RVs as part of the delivery process, including extended vehicle service contracts, tire and wheel protection, guaranteed auto protection and property insurance. The company's parts and services and other include: repair and maintenance, installation of parts and accessories, collision repair, parts and accessories store, RV rentals, and RV campground.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

Qurate Retail owns interests in subsidiaries and other companies which are primarily engaged in the video and online commerce industries. The company's principal businesses and assets include its consolidated subsidiaries: QVC, Inc., which curates and sells a variety of consumer products; HSN, Inc., which operates an e-commerce website, a mobile application, social pages and Shop By Remote technology; Cornerstone Brands, Inc., which consists of a portfolio of aspirational home and apparel brands; and Zulily, LLC, which is an online retailer providing merchandise including women's, children's and men's apparel and other products such as home, accessories and beauty products.

Spok Holdings provides a suite of unified clinical communication and collaboration solutions that include call center operations, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications and public safety solutions. The company also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize mission clinical communications. These solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications.